Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages
New Jersey Collateral License Agreement is a legal document that outlines the terms and conditions between Gentling, Inc. and The University of North Texas Health Science Center for collaborative research, development, and commercialization of certain technologies or intellectual property. This agreement allows the parties involved to protect their rights, interests, and ownership of the collateral. In this specific agreement, Gentling, Inc. and The University of North Texas Health Science Center collaborate to explore new advancements in healthcare and medical research. The agreement ensures that the technology, patents, and intellectual property developed as a result of the collaboration are properly licensed and protected. Keywords: New Jersey, Collateral License Agreement, Gentling, Inc., The University of North Texas Health Science Center, collaborative research, development, commercialization, technologies, intellectual property, rights, ownership, healthcare, medical research, patents, licensing, protection. Different types of New Jersey Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center could include: 1. Research Collaboration Agreement: This type of agreement outlines the terms of collaboration between the two entities for joint research projects, exchange of information, and potential commercialization of the results. 2. Intellectual Property License Agreement: This agreement focuses on the licensing of specific intellectual property, such as patents, copyrights, or trademarks. It ensures that both parties have the rights to use, develop, and commercialize the licensed technology. 3. Commercialization Agreement: This agreement addresses the terms and conditions for the commercialization or marketing of a specific product, process, or technology resulting from the collaborative research efforts. It includes provisions for royalties, marketing strategies, and distribution. 4. Technology Transfer Agreement: This type of agreement facilitates the transfer of technology or know-how from one party to another. It ensures that the technology developed through the collaboration is effectively transferred and properly utilized by both parties. 5. Confidentiality Agreement: While not strictly a collateral license agreement, a confidentiality agreement is often included in partnerships to protect sensitive information shared between Gentling, Inc. and The University of North Texas Health Science Center. It ensures that both parties maintain confidentiality and do not disclose any proprietary information to unauthorized individuals or organizations. These different types of agreements cater to the specific goals and objectives of the collaboration between Gentling, Inc. and The University of North Texas Health Science Center while safeguarding their rights, commercial interests, and shared intellectual property.
New Jersey Collateral License Agreement is a legal document that outlines the terms and conditions between Gentling, Inc. and The University of North Texas Health Science Center for collaborative research, development, and commercialization of certain technologies or intellectual property. This agreement allows the parties involved to protect their rights, interests, and ownership of the collateral. In this specific agreement, Gentling, Inc. and The University of North Texas Health Science Center collaborate to explore new advancements in healthcare and medical research. The agreement ensures that the technology, patents, and intellectual property developed as a result of the collaboration are properly licensed and protected. Keywords: New Jersey, Collateral License Agreement, Gentling, Inc., The University of North Texas Health Science Center, collaborative research, development, commercialization, technologies, intellectual property, rights, ownership, healthcare, medical research, patents, licensing, protection. Different types of New Jersey Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center could include: 1. Research Collaboration Agreement: This type of agreement outlines the terms of collaboration between the two entities for joint research projects, exchange of information, and potential commercialization of the results. 2. Intellectual Property License Agreement: This agreement focuses on the licensing of specific intellectual property, such as patents, copyrights, or trademarks. It ensures that both parties have the rights to use, develop, and commercialize the licensed technology. 3. Commercialization Agreement: This agreement addresses the terms and conditions for the commercialization or marketing of a specific product, process, or technology resulting from the collaborative research efforts. It includes provisions for royalties, marketing strategies, and distribution. 4. Technology Transfer Agreement: This type of agreement facilitates the transfer of technology or know-how from one party to another. It ensures that the technology developed through the collaboration is effectively transferred and properly utilized by both parties. 5. Confidentiality Agreement: While not strictly a collateral license agreement, a confidentiality agreement is often included in partnerships to protect sensitive information shared between Gentling, Inc. and The University of North Texas Health Science Center. It ensures that both parties maintain confidentiality and do not disclose any proprietary information to unauthorized individuals or organizations. These different types of agreements cater to the specific goals and objectives of the collaboration between Gentling, Inc. and The University of North Texas Health Science Center while safeguarding their rights, commercial interests, and shared intellectual property.